Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 408
Selected: 0
NCT IDTitle
NCT03767075A Modular Multi-Basket Trial to Improve Personalized Medicine in Cancer Patients (Basket of Baskets)
NCT01472029Explorative Phase II Study of Perioperative Treatment in Patients With Adenocarcinoma of the Gastroesophageal Junction or Stomach
NCT00562952Nt-proBNP Guided Primary Prevention of CV Events in Diabetic Patients
NCT035905355th Generation cTnT in ED ACS
NCT05050214Obinutuzumab in Primary MN
NCT00223301Safety Study of Combination Therapy With Intramuscular Avonex and Oral Cellcept in Patients With Multiple Sclerosis
NCT01640444Influence of BRAF and PIK3K Status on the Efficacy of 5-Fluorouracil/Leucovorin/Oxaliplatin (FOLFIRI) Plus Bevacizumab or Cetuximab in Patients With RAS Wild-type Metastatic Colorectal Carcinoma and < 3 Circulating Tumor Cells (CTC)
NCT05765084Integration of the PD-L1 Inhibitor Atezolizumab and WT1/DC Vaccination Into Platinum/Pemetrexed-based First-line Treatment for Epithelioid Malignant Pleural Mesothelioma
NCT00407732Overcoming Psychiatric Barriers to the Treatment of Hepatitis C
NCT00407186Randomized Phase III Trial of Adjuvant Chemotherapy or Chemoradiotherapy in Resectable Gastric Cancer (CRITICS)
NCT00620269Induction Chemotherapy Followed by CCRT According to EGFR Mutation Status in NSCLC III
NCT00855894A Study of the Combination of Erlotinib and Pertuzumab in Patients With Relapsed Non-small Cell Lung Cancer
NCT00784446First-line Therapy of Stage IV Colorectal Cancer
NCT00275548Safety and Effectiveness Using Pegasys and Copegus in Recipients of Liver Transplantation With Hepatitis C
NCT01370772Intensified Rituimab Prephase Before FCR in Untreated B-CLL
NCT01458730Nordic Study in Newly Diagnosed Primary Central Nervous System (CNS) Lymphoma
NCT01306409Neocytolysis in the Treatment of Renal Anemia With Erythropoieses Stimulating Agents (ESA)
NCT01303887A Trial Looking at Rituximab and Chemotherapy as a Treatment for Follicular Lymphoma in Elderly Patients
NCT01028092mTor-inhibitor (EVERolimus) Based Immunosuppressive Strategies for CNI Minimisation in OLD for Old Renal Transplantation
NCT04578106Omission of Surgery in Clinically Low-risk HER2positive Breast Cancer With High HER2 Addiction and a Complete Response Following Standard Anti-HER2-based Neoadjuvant Therapy
NCT00438152Lopinavir Capsules to Kaletra or Invirase Tablets
NCT00363116A Trial of Two Daclizumab Dosing Strategies vs. No Induction Treatment With Tacrolimus, Mycophenolate Mofetil , & Steroids for the Prevention of Acute Allograft Rejection in Simultaneous Kidney/Pancreas Transplant Recipients
NCT01565200HER2 Imaging Study to Identify HER2 Positive Metastatic Breast Cancer Patient Unlikely to Benefit From T-DM1
NCT02987400Combination of Obinutuzumab and Venetoclax in Relapsed or Refractory DLBCL
NCT00275132Erlotinib in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer
NCT05802836Dynamics of the Anti-factor VIII Antibody Signature During Treatment With Emicizumab
NCT00724022Phase IV Study to Evaluate Calcineurin Inhibitor Reduced, Steroid Free Immunosuppression After Renal Transplantation
NCT01015352Azacitidine Combined to Epoetin Beta in International Prognostic Scoring System (IPSS) Low-risk and Intermediate-1 Myelodysplastic Syndrome (MDS) Patients, Resistant to Erythropoetin-stimulating Agents (ESA)
NCT05966233R-DHAP vs POLA-R-DHAP Followed by Autologous Transplant as First Salvage Treatment in Patient With Relapsed or Refractory Diffuse Large B Cell Lymphoma
NCT03324633Inter Cohorts and Clinical Centres Collaborations of Subjects Co-infected With HIV and HCV
NCT03197805Assessment of the Impact of RNA Genomic Profile on Treatment Decision-making in HER2 Equivocal Breast Cancer Patients
NCT00952003Oxaliplatin/Irinotecan/Bevacizumab Followed by Docetaxel/Bevacizumab in Inoperable Locally Advanced or Metastatic Gastric Cancer Patients
NCT00645606Rituximab Maintenance Versus Observation After First-line Immunochemotherapy by FCR in Older Patients With Chronic Lymphocytic Leukemia
NCT04144270The Importance of Muscle Function in Patients With Disseminated Bladder Cancer
NCT00273767Preliminary Administration of EPO and Markers of Cardiac Ischemia Induced by CPB
NCT03548428Stereotaxic Body Irradiation of Oligometastase in Sarcoma (Stereosarc)
NCT00457301Using Health-related Quality of Life (HRQL) in Routine Clinical Care
NCT05008081The CATALINA Study
NCT01085838Erlotinib in Higher Risk Myelodysplastic Syndrome
NCT05293015NP-Supported Multidisciplinary Diabetes Management During Perioperative Period
NCT03554343Sun May Arise on SMA : Newborn Screening of Spinal Muscular Atrophy in Belgium
NCT03385668Pilot Study of Pirfenidone in Pulmonary Fibrosis With Anti-myeloperoxydase Antibodies
NCT03915678Atezolizumab Combined With BDB001 AnD Immunogenic Radiotherapy in Patients With Advanced Solid Tumors
NCT00694408A Pilot Trial of Pediatric Liver Transplantation Without Steroids
NCT04808245A MultIceNTER Phase I Peptide VaCcine Trial for the Treatment of H3-Mutated Gliomas
NCT00284531Use of Daclizumab for the Prevention of Allograft Rejection in Pediatric Heart Transplant Patients
NCT01450137Tocilizumab for Patients With Giant Cell Arteritis
NCT01126866Curative Resectability of Not Optimally Resectable Liver and/or Lung Metastases From Colorectal Carcinoma (CRC) Under Intensified Chemotherapy
NCT02049853The Triple A Initiative Study ("Aktionsbündnis Akute Atemnot")
NCT02666898Phase II Trial GA101 Inbrutinib B CLL